IL6 and depressive symptom measurement: Our findings corroborate previous studies reporting anxiety (27.3%) and depression (39%) in hospitalized COVID-19 patients, with both conditions correlating with longer hospital stays and elevated inflammatory markers (D-dimer, IL-6, IL-10) [56].